Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835
Books209
All textbooksMedical textbooksHuman anatomyOrganisms & biodiversityOther sciences
Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT›References

Continue where you left off ()

GO BEYOND THE PAGEReading is just the beginning.

Turn scientific reading into research. Compare studies, examine evidence, and organize your findings in EvidenceHelix Workspace.

Explore Research Workspace →

Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT · References

References

CC BY 4.0 · NIHR Journals Library · approximately 6 min read

  1. Global Burden of Disease Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1151–210.28919116
  2. Knight M, Bunch K, Tuffnell D, Jayakody H, Shakespeare J, Kotnis R, et al. Saving Lives, Improving Mothers’ Care – Lessons Learned to Inform Maternity Care From The UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2014–16. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2018.
  3. Acosta CD, Kurinczuk JJ, Lucas DN, Tuffnell DJ, Sellers S, Knight M, United Kingdom Obstetric Surveillance System. Severe maternal sepsis in the UK, 2011–2012: a national case-control study. PLOS Med 2014;11:e1001672. 10.1371/journal.pmed.100167225003759
  4. Declercq E, Barger M, Cabral HJ, Evans SR, Kotelchuck M, Simon C, et al. Maternal outcomes associated with planned primary caesarean births compared with planned vaginal births. Obstet Gynecol 2007;109:669–77. 10.1097/01.AOG.0000255668.20639.4017329519
  5. National Institute for Health and Care Excellence. Caesarean Section. NICE Clinical Guideline 132. London: NICE; 2011.
  6. Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after caesarean section. Cochrane Database Syst Rev 2014;10:CD007482. 10.1002/14651858.CD007482.pub3
  7. Acosta CD, Bhattacharya S, Tuffnell D, Kurinczuk JJ, Knight M. Maternal sepsis: a Scottish population-based case-control study. BJOG 2012;119:474–83. 10.1111/j.1471-0528.2011.03239.x22251396
  8. Acosta CD, Knight M, Lee HC, Kurinczuk JJ, Gould JB, Lyndon A. The continuum of maternal sepsis severity: incidence and risk factors in a population-based cohort study. PLOS ONE 2013;8:e67175. 10.1371/journal.pone.006717523843991
  9. Knight M, Acosta C, Brocklehurst P, Cheshire A, Fitzpatrick K, Hinton L, et al. Beyond maternal death: improving the quality of maternal care through national studies of ‘near-miss’ maternal morbidity. Programme Grants Appl Res 2016;4(9). 10.3310/pgfar04090
  10. Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM. Antibiotic prophylaxis for operative vaginal delivery. Cochrane Database Syst Rev 2017;8:CD004455. 10.1002/14651858.CD004455.pub4
  11. Johnson A, Thakar R, Sultan AH. Obstetric perineal wound infection: is there underreporting? Br J Nurs 2012;21:S28, S30, S32–5. 10.12968/bjon.2012.21.Sup5.S28
  12. Perkins E, Tothill S, Kettle C, Bick D, Ismail K. Women’s views of important outcomes following perineal repair. BJOG 2008;115:152.
  13. NHS Digital. NHS Maternity Statistics, England 2017–18. Leeds: NHS Digital; 2018. URL: https://digital.nhs.uk/data-and-information/publications/statistical/nhs-maternity-statistics/2017-18 (accessed 12 December 2018).
  14. National Institute for Health and Care Excellence. Intrapartum Care for Healthy Women and Babies. Clinical Guidance 190 (CG190). 2014. URL: www.nice.org.uk/guidance/cg190 (accessed 15 April 2015).
  15. Royal College of Obstetricians and Gynaecologists. Green-top Guideline Number 26: Operative Vaginal Delivery. London: RCOG; 2011. URL: www.rcog.org.uk/globalassets/documents/guidelines/gtg_26.pdf (accessed 17 April 2018).
  16. World Health Organization. WHO Recommendations for Prevention and Treatment of Maternal Peripartum Infections. Geneva: World Health Organization; 2015.
  17. Royal College of Obstetricians and Gynaecologists (RCOG). Green-top Guideline No. 64b. Bacterial Sepsis following Pregnancy. London: RCOG; 2012.
  18. Wloch C, Lamagni T, Connelly J, Harrington P, Elgohari S, van Hoek AJ, et al. Estimating the Healthcare Costs of Post-surgical Infection in Patients Undergoing Caesarean Section in England. Paper presented at Edinburgh: European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE), 2012.
  19. Department of Health and Social Care. Getting Ahead of the Curve. London: Department of Health and Social Care; 2002.
  20. Department of Health and Social Care. UK Five Year Antimicrobial Resistance Strategy 2013 to 2018. Department of Health and Social Care; 2013. URL: www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf (accessed 23 October 2013).
  21. Chief Medical Officer. Annual Report of the Chief Medical Officer, Volume Two, 2011, Infections and the Rise of Antimicrobial Resistance. London: Department of Health and Social Care; 2013.
  22. European Centre for Disease Control and Prevention (ECDC). Poor Pregnancy Outcomes Associated with Maternal Infection with the A(H1N1) 2009 Virus During the Pandemic – Findings from a European Cohort Study. Solna Municipality: ECDC; 2011. URL: www.ecdc.europa.eu/en/activities/sciadvice/Lists/ECDC%20Reviews/ECDC_DispForm.aspx?List=512ff74f-77d4-4ad8-b6d6-bf0f23083f30&ID=1157&MasterPage=1 (accessed 31 July 2011).
  23. McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet 2009;374:1105–12. 10.1016/S0140-6736(09)61116-819782876
  24. Stensballe LG, Simonsen J, Jensen SM, Bønnelykke K, Bisgaard H. Use of antibiotics during pregnancy increases the risk of asthma in early childhood. J Pediatr 2013;162:832–8.e3. 10.1016/j.jpeds.2012.09.04923140881
  25. Örtqvist AK, Lundholm C, Halfvarson J, Ludvigsson JF, Almqvist C. Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study. Gut 2019;68:218–25. 10.1136/gutjnl-2017-31435229321166
  26. Gülmezoglu AM, Duley L. Use of anticonvulsants in eclampsia and pre-eclampsia: survey of obstetricians in the United Kingdom and Republic of Ireland. BMJ 1998;316:975–6. 10.1136/bmj.316.7136.9759550956
  27. McCall SJ, Bunch KJ, Brocklehurst P, D’Arcy R, Hinshaw K, Kurinczuk JJ, et al. The incidence, characteristics, management and outcomes of anaphylaxis in pregnancy: a population-based descriptive study. BJOG 2018;125:965–71. 10.1111/1471-0528.1504129193647
  28. Knight M, Mottram L, Gray S, Partlett C, Juszczak E, ANODE collaborative group. Prophylactic antibiotics for the prevention of infection following operative vaginal delivery (ANODE): study protocol for a randomised controlled trial. Trials 2018;19:395. 10.1186/s13063-018-2787-030041702
  29. Mohamed-Ahmed O, Hinshaw K, Knight M. Operative vaginal delivery and post-partum infection. Best Pract Res Clin Obstet Gynaecol 2018;56:93–106. 10.1016/j.bpobgyn.2018.09.00530992125
  30. Knight M, Chiocchia V, Partlett C, Rivero-Arias O, Hua X, Hinshaw K, et al. Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial. Lancet 2019;393:2395–403. 10.1016/S0140-6736(19)30773-131097213
  31. Centers for Disease Control and Prevention (CDCP). CDC/NHSN Surveillance Definitions for Specific Types of Infections. Atlanta, GA: CDCP; 2013. URL: www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf (accessed 15 November 2013).
  32. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001;322:1089–93. 10.1136/bmj.322.7294.108911337436
  33. Public Health England (Health Protection Agency). Protocol for the Surveillance of Surgical Site Infection. London: Public Health England; 2013. URL: http://webarchive.nationalarchives.gov.uk/10080709222242/http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1194947388966 (accessed 18 April 2019).
  34. McCandlish R, Bowler U, van Asten H, Berridge G, Winter C, Sames L, et al. A randomised controlled trial of care of the perineum during second stage of normal labour. Br J Obstet Gynaecol 1998;105:1262–72. 10.1111/j.1471-0528.1998.tb10004.x9883917
  35. Dudley L, Kettle C, Thomas PW, Ismail KM. Perineal resuturing versus expectant management following vaginal delivery complicated by a dehisced wound (PREVIEW): a pilot and feasibility randomised controlled trial. BMJ Open 2017;7:e012766. 10.1136/bmjopen-2016-012766
  36. Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ 2018;27:7–22. 10.1002/hec.356428833869
  37. Dudley L, Kettle C, Waterfield J, Ismail KM. Perineal resuturing versus expectant management following vaginal delivery complicated by a dehisced wound (PREVIEW): a nested qualitative study. BMJ Open 2017;7:e013008. 10.1136/bmjopen-2016-013008
  38. Joint Formulary Committee. British National Formulary. URL: www.medicinescomplete.com (accessed August 2019).
  39. Curtis L, Burns A. Unit Costs of Health and Social Care 2017. University of Kent, Personal Social Services Research Unit; 2017. URL: www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2017 (accessed 17 January 2019).
  40. NHS Improvement. NHS Reference Costs 2017/18. URL: https://improvement.nhs.uk/resources/reference-costs/#rc1718 (accessed 17 January 2019).
  41. Mackeen AD, Packard RE, Ota E, Berghella V, Baxter JK. Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing caesarean delivery. Cochrane Database Syst Rev 2014;12:CD009516. 10.1002/14651858.CD009516.pub2
  42. Heitmann JA, Benrubi GI. Efficacy of prophylactic antibiotics for the prevention of endomyometritis after forceps delivery. South Med J 1989;82:960–2. 10.1097/00007611-198908000-000072669154
  43. Axelsson D, Brynhildsen J, Blomberg M. Postpartum infection in relation to maternal characteristics, obstetric interventions and complications. J Perinat Med 2018;46:271–8. 10.1515/jpm-2016-038928672754
  44. Fernandez R, Griffiths R. Water for wound cleansing. Cochrane Database Syst Rev 2012;2:CD003861. 10.1002/14651858.CD003861.pub3
  45. Tay SK, Soong SL, Choo BM. Is routine procaine spirit application necessary in the care of episiotomy wound? Singapore Med J 1999;40:581–3.10628247
  46. Bonet M, Nogueira Pileggi V, Rijken MJ, Coomarasamy A, Lissauer D, Souza JP, Gülmezoglu AM. Towards a consensus definition of maternal sepsis: results of a systematic review and expert consultation. Reprod Health 2017;14:67. 10.1186/s12978-017-0321-628558733
  47. Bonet M, Souza JP, Abalos E, Fawole B, Knight M, Kouanda S, et al. The global maternal sepsis study and awareness campaign (GLOSS): study protocol. Reprod Health 2018;15:16. 10.1186/s12978-017-0437-829382352
  48. Knight M, Kenyon S, Brocklehurst P, Neilson J, Shakespeare J, Kurinczuk J, et al. Saving Lives, Improving Mothers’ Care – Lessons Learned to Inform Future Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–12. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2014.
  49. Macleod M, Goyder K, Howarth L, Bahl R, Strachan B, Murphy DJ. Morbidity experienced by women before and after operative vaginal delivery: prospective cohort study nested within a two-centre randomised controlled trial of restrictive versus routine use of episiotomy. BJOG 2013;120:1020–6. 10.1111/1471-0528.1218423464382
  50. Committee on Practice Bulletins – Obstetrics. ACOG Practice Bulletin No. 154: Operative Vaginal Delivery. Obstet Gynecol 2015;126:e56–65. 10.1097/AOG.000000000000114726488523
  51. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Instrumental Vaginal Birth. Melbourne, VA: Royal Australian and New Zealand College of Obstetricians and Gynaecologists; 2015.
  52. Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press; 2017. URL: https://bnf.nice.org.uk/medicinal-forms/co-amoxiclav.html (accessed 22 January 2019).
  53. Curtis L, Burns A. Unit Costs of Health and Social Care 2015. Canterbury: Personal Social Services Research Unit, University of Kent; 2015.
← Discussion and conclusionsAcknowledgements →

Attribution. Marian Knight; Virginia Chiocchia; Christopher Partlett; Oliver Rivero-Arias; Xinyang Hua; Ursula Bowler et al. (2019). Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT. NIHR Journals Library. Copyright © Queen’s Printer and Controller of HMSO 2019. This work was produced by Knight et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK. Licensed under CC BY 4.0. NCBI Bookshelf NBK547343. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support